Defer-based non-stenting: a promising approach for STEMI

EuroIntervention 2022;18:446-447. DOI: 10.4244/EIJ-E-22-00023

Haibo Jia
Haibo Jia1,2, MD, PhD; Luping He1,2, MD
1. Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; 2. The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China
Early restoration of antegrade blood flow is key for patients with ST-segment elevation myocardial infarction (STEMI). Primary percutaneous coronary intervention (PCI) with stent implantation is routinely recommended in current guidelines for STEMI1. However, for those with stable blood flow and non-obstructive residual lesions, the non-stenting approach might be an option. Consequently, acute and chronic stent-related complications (distal embolisation, stent thrombosis, and restenosis) could be avoided, especially in younger STEMI patients with longer life expectancy. With a better understanding of the pathophysiology of STEMI, new concepts are emerging for a tailored management of STEMI, such as deferred PCI. The contradictory results ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
ARC-HBR criteria and TAVR: not all high bleeding risk patients look alike

Latest news